1.
Steliarova-Foucher E,
Stiller C,
Kaatsch P et al (2004) Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study.
Lancet 364:2097–2105
2.
Kluge R,
Kurch L,
Georgi T,
Metzger M,
Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.
Semin Nucl Med.
2017 May;47(3):242-257
3.
Körholz D.
atal Second international Inter-Group Study for classical Hodgkin`s Lymphoma in Children and Adolescents.
May 15,2017
4.
Mauz-Körholz C,
Metzger M L,
Kelly K M,
Schwartz C L,
Castellanos M E,
Dieckmann K,
Kluge R,
Körholz D (2015) Pediatric Hodgkin Lymphoma.
J Clin Oncol.
Sep 20;33(27):2975-85
5.
Kwee TC,
Kwee RM,
Nievelstein RA (2008) Imaging in staging of malignant lymphoma: a systematic review.
Blood 111:504–516
6.
Juweid ME,
Stroobants S,
Hoekstra OS et al Imaging Subcommittee of International Harmonization Project in Lymphoma (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
J Clin Oncol 25:571–578
7.
la Fougère C,
Hundt W,
Bröckel N et al .
Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non- Hodgkin’s lymphoma.
Eur J Nucl Med Mol Imaging 2006;33(12):1417–1425
8.
Kwee TC,
Takahara T,
Ochiai R,
Nievelstein RA,
Luijten PR.
Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology.
European Radiology 2008;18(9):1937–52.
9.
Nievelstein RA,
Littooij AS.
Whole-body MRI in paediatric oncology.
Radiol Med.
2016 May;121(5):442-53
10.
Littooij AS,
Kwee TC,
Barber I,
Granata C,
Vermoolen MA,
Enríquez G,
Zsíros J,
Soh SY,
de Keizer B,
Beek FJ,
Hobbelink MG,
Bierings MB,
Stoker J,
Nievelstein RA.
Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.
Eur Radiol.
2014 May;24(5):1153-65
11.
Zink D,
Fischer AH,
Nickerson JA.
Nuclear structure in cancer cells.
Nat Rev Cancer.
2004 Sep;4(9):677-87
12.
Zheng W,
Aspelund A,
Alitalo K.
Lymphangiogenic factors,
mechanisms,
and applications.
J Clin Invest.
2014 Mar;124(3):878-87
13.
Uhl M,
Altehoefer C,
Kontny U,
Il'yasov K,
Büchert M,
Langer M.
MRI-diffusion imaging of neuroblastomas: first results and correlation to histology.
Eur Radiol.
2002 Sep;12(9):2335-8
14.
Holzapfel K,
Duetsch S,
Fauser C,
Eiber M,
Rummeny E J,
Gaa J Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
Eur Radiol.
2009 December;72(3):381-387
15.
Stéphane V,
Samuel B,
Vincent D,
Joelle G,
Remy P,
Francois GG,
Jean-Pierre T.
Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
Eur J Radiol.
2013 Nov;82(11):2011-7.
16.
Wong CS,
Gong N,
Chu YC,
Anthony MP,
Chan Q,
Lee HF,
Chu KM,
Khong PL Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.
Eur J Radiol.
2012 Sep;81(9):2122-6
17.
Punwani S,
Taylor SA,
Bainbridge A et al (2010) Pediatric and adolescent lymphoma: comparison of whole-body STIR half- Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging.
Radiology 255:182–190
18.
Kellenberger CJ,
Miller SF,
Khan M,
Gilday DL,
Weitzman S,
Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children.
Eur Radiol 14:1829–1841
19.
Mosavi F,
Wassberg C,
Selling J,
Molin D,
Ahlström H (2015) Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Clin Radiol 70(11):1229-36
20.
Stecco A,
Buemi F,
Quagliozzi M,
et al Staging of Primary Abdominal Lymphomas: Comparison of Whole-Body MRI with Diffusion-Weighted Imaging and 18F-FDG-PET/CT.
Gastroenterol Res Pract.
2015;2015:104794
21.
Teoh EJ,
McGowan DR,
Macpherson RE,
Bradley KM,
Gleeson FV,
Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system.
J Nucl Med.
2015;56:1447–1452.
22.
Punwani S,
Prakash V,
Bainbridge A,
Taylor SA,
Bandula S,
Olsen OE,
Hain SF,
Shankar A,
Daw S,
Humphries P.
Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma? Cancer Biomark.
2010;7(4):249-59
23.
Feasibility of diffusion-weighted imaging with DWIBS in staging Hodgkin lymphoma in pediatric patients: comparison with PET/CT.
Baranska D,
Matera K,
Podgorski M,
Gorska-Chrzastek M,
Krajewska K,
Trelinska J,
Grzelak P.
MAGMA.
2018 Nov 29.